CHC patients carrying the homozygous wild-type genotype SLC40A1 rs1439816 (GG) had an increased risk of severe fibrosis (F3/4) before DAA treatment compared with carriers of the C allele (GC or CC). Here, SLC40A1 is linked to cryohydrocytosis.